Keyphrases
Alzheimer's Disease
33%
Body Iron Stores
33%
Brain Iron
33%
Causal Factors
33%
Cell Damage
66%
Cell Function
33%
Chelation
33%
Chelator
33%
Clinical Setting
33%
Deferiprone
100%
Frataxin
66%
Friedreich Ataxia
100%
Functional Improvement
33%
In Vitro Model
33%
Iron Accumulation
66%
Iron Chelation
33%
Labile Iron
33%
Minor Change
33%
Mitochondria
33%
Moderate Dose
33%
Neurodegeneration with Brain Iron Accumulation
33%
Neurodegenerative Diseases
66%
Neurological Disorders
100%
Oxidative Damage
33%
Parkinson's Disease
33%
Patient Selection
33%
Sequester
33%
Siderophore
100%
Therapeutic Potential
100%
Therapeutic Strategies
33%
Medicine and Dentistry
Alzheimer's Disease
33%
Cell Damage
66%
Cell Function
33%
Chelating Agent
33%
Deferiprone
100%
Disease
33%
Frataxin
66%
Friedreich's Ataxia
100%
In Vitro
33%
Iron
100%
Iron Storage
33%
Mitochondrion
33%
Neurodegenerative Disorder
66%
Neurologic Disease
100%
Pantothenate Kinase-Associated Neurodegeneration
33%
Parkinson's Disease
33%
Siderophore
100%
Neuroscience
Alzheimer's Disease
33%
Ataxia
100%
Cell Damage
66%
Cell Function
33%
Chelating Agent
33%
Deferiprone
100%
Frataxin
66%
In Vitro
33%
Mitochondrion
33%
Neurodegenerative Disorder
66%
Neurological Disorder
100%
Pantothenate Kinase-Associated Neurodegeneration
33%
Parkinson's Disease
33%
Siderophore
100%
Pharmacology, Toxicology and Pharmaceutical Science
Alzheimer's Disease
33%
Chelating Agent
33%
Deferiprone
100%
Disease
100%
Frataxin
66%
Friedreich's Ataxia
100%
Iron
100%
Neurodegeneration with Brain Iron Accumulation
33%
Neurologic Disease
100%
Parkinson's Disease
33%
Siderophore
100%
Biochemistry, Genetics and Molecular Biology
Cell Damage
66%
Cell Function
33%
Chelation
33%
Frataxin
66%
Friedreich's Ataxia
100%
Iron Chelation
33%
Iron Storage
33%
Mitochondrion
33%
Siderophore
100%